SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-308327
Filing Date
2022-12-19
Accepted
2022-12-19 16:12:02
Documents
12
Period of Report
2022-12-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d402136d8k.htm   iXBRL 8-K 25870
  Complete submission text file 0001193125-22-308327.txt   151862

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA scph-20221215.xsd EX-101.SCH 2882
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20221215_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20221215_pre.xml EX-101.PRE 11729
6 EXTRACTED XBRL INSTANCE DOCUMENT d402136d8k_htm.xml XML 3461
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 221471202
SIC: 2834 Pharmaceutical Preparations